LifeWave - Profile

LifeWave Ltd., founded in 2000, is a public company listed on the Tel Aviv Stock Exchange (TASE; LIFE) www.tase.co.il. By utilizing its enabling platform technology; BME - BioMedical Electrotherapies, LifeWave has focused on the development and commercialization of innovative noninvasive electrotherapies in biomedicine.

LifeWave - Mission

We are committed to advance the science of novel bioelectrical signals, discovered in humans, to innovative electrotherapies that create a new standard of care, restore health or even save lives.

LifeWave - Products & Innovations

LifeWave - first breakthrough medical application, launched in 2007, was the BST - Bioelectrical Signal Therapy™, a pioneering novel electrotherapy for the noninvasive treatment of difficult to treat chronic wounds:

• Diabetic Foot Ulcers
• Pressure (Decubitus) Ulcers
• Vascular (Arterial and Venous) Leg Ulcers
• Others, which are resistant to standard or more complex treatments

The safety and efficacy of BST were evaluated in a multicentre randomized controlled study on grade III pressure ulcers as published in the Journal of the European Wound Management Association - EWMA 2007. The rapid therapeutic response to the BST was observed on hard–to–heal chronic wounds that had failed to heal after 10 and even 20 years of standard therapy as published in the JWC (Journal of Wound Care) 2010. The BST has regulatory approvals for the intended use of chronic wounds treatment in Europe (CE), Canada, Brazil and Israel. FDA approval is pending. LifeWave - Science & Clinical Recognition LifeWave - fundamental findings in the biomedicine of wound healing are recognized by Key Opinion Leaders (KOL) who have strategic roles in the world's scientific and clinical arena. LifeWave -international advisory board includes; * Prof. Luc Teot - Montpellier University Medical Center, France. Expertise - Wound Care. * Prof. Jim Collins - Boston University and Wyss Institute of Harvard University, USA. Expertise - Stochastic Resonance Neurophysiology * Prof. Elia Ricci - Turin "Casa di Cura" Medical Institute, Italy. Expertise - Wound Care. LifeWave - Business Strategy LifeWave is also conducting research on its innovative platform technology for treating vascular and systemic neurological disorders. After years of fundamental research and development of its patents portfolio, LifeWave represents a strong position in the business of innovative biomedical electrotherapies. LifeWave wishes to establish strategic alliances with partners that share its business objectives.

References

     

2. Ohry, A., Goren, O. The effects of BST electrostimulation on healing of pressure ulcers: results of a multi-center, double blind, randomized, placebo controlled study. EWMA J 2007; 7: oral abstract no. 66.

     

    

   

5. Pamela E. et al., Electrical Stimulation Therapy Increases Rate of Healing of Pressure Ulcers in Community-Dwelling People With Spinal Cord Injury. Arch Phys Med Rehabil 2010; 91: 5, 669-832.